MedTrace Logo

Study of Cellular Heterogeneity in Patients With Mastocytosis

NCT06432556 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2024-05-29

No results posted yet for this study

Summary

This study will aim to study the heterogeneity of skin-resident mast cells and of blood circulating hematopoietic progenitors in patients suffering from isolated Cutaneous Mastocytosis and from systemic Mastocytosis with skin lesions.

Conditions

  • Mastocytosis

Interventions

GENETIC

scRNAseq

A blood test tube (only for scRNAseq, 2 tubes of 10 ml per patient)

PROCEDURE

two Skin biopsies

2 skin biopsies from a lesional area

PROCEDURE

one Skin biopsies

1 skin biopsies from a lesional area

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Cristina Bulai Livideanu, MD · Toulouse univiversity hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2026-06-08
Completion
2026-06-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06432556 on ClinicalTrials.gov